Cargando…
What is Currently the Best for Adenocarcinoma without Driver Mutation?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030658/ https://www.ncbi.nlm.nih.gov/pubmed/29926553 http://dx.doi.org/10.4046/trd.2018.0024 |
_version_ | 1783337172802207744 |
---|---|
author | Park, Cheol-Kyu Oh, In-Jae Kim, Young-Chul |
author_facet | Park, Cheol-Kyu Oh, In-Jae Kim, Young-Chul |
author_sort | Park, Cheol-Kyu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6030658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
record_format | MEDLINE/PubMed |
spelling | pubmed-60306582018-07-07 What is Currently the Best for Adenocarcinoma without Driver Mutation? Park, Cheol-Kyu Oh, In-Jae Kim, Young-Chul Tuberc Respir Dis (Seoul) Editorial The Korean Academy of Tuberculosis and Respiratory Diseases 2018-07 2018-06-19 /pmc/articles/PMC6030658/ /pubmed/29926553 http://dx.doi.org/10.4046/trd.2018.0024 Text en Copyright©2018. The Korean Academy of Tuberculosis and Respiratory Diseases http://creativecommons.org/licenses/by-nc/4.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Editorial Park, Cheol-Kyu Oh, In-Jae Kim, Young-Chul What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title | What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title_full | What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title_fullStr | What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title_full_unstemmed | What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title_short | What is Currently the Best for Adenocarcinoma without Driver Mutation? |
title_sort | what is currently the best for adenocarcinoma without driver mutation? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030658/ https://www.ncbi.nlm.nih.gov/pubmed/29926553 http://dx.doi.org/10.4046/trd.2018.0024 |
work_keys_str_mv | AT parkcheolkyu whatiscurrentlythebestforadenocarcinomawithoutdrivermutation AT ohinjae whatiscurrentlythebestforadenocarcinomawithoutdrivermutation AT kimyoungchul whatiscurrentlythebestforadenocarcinomawithoutdrivermutation |